LYON, France, Jan. 25, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that a meeting with the U.S. Food and Drug Administration (FDA) has been scheduled for later this month. The discussion follows the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee, held on December 11, 2009
